LEADIANT BIOSCIENCES LIMITED

PaymentCheck Score 2025
80Good
8.0vs last year
#1729 in UK
#10 in Life Sciences And Medical Technology
#746 in London

Company Information

Company Number
09544704
Registered Address
21 Holborn Viaduct, London, United Kingdom, EC1A 2DY
Status
Active
Employee Count
12
Turnover
£50,299,000
EBITDA
£41,096,000

Additional Details

Company Type
Private limited Company
Incorporated On
15 April 2015
Nature of Business
46460 - Wholesale of pharmaceutical goods
Industries
Life Sciences And Medical Technology
Region
London

Time to Pay

Average Time to Pay
27 days
Shortest Period:30 days
Longest Period:0 days
Max Contractual:60 days

Payment Timeline

Within 30 Days
64%
31-60 Days
35%
After 60 Days
1%
Not Paid Within Terms44%

Payment Features

Participates in Codes✗ No
E-Invoicing✗ No
Supply Chain Finance✗ No

Payment Score History

Excellent (80+) Good (60-79) Fair (40-59) Poor (20-39) Very Poor (<20)

Performance Reports History

Reporting Period Filed: 2024-07-30
Reporting PeriodFiling DateAverage Time to Pay (days)Paid within 30 daysPaid 31-60 daysPaid after 60 daysNot Paid within Terms
01 Jan 2025 - 30 Jun 202510 Oct 20252476%23%1%34%
01 Jan 2024 - 30 Jun 202430 Jul 20242764%35%1%44%
01 Jul 2023 - 31 Dec 202330 Jan 20242951%46%3%56%
01 Jul 2021 - 31 Dec 202128 Jan 20222865%28%7%39%
01 Jan 2021 - 30 Jun 202126 Jul 20212769%23%8%41%
01 Jan 2020 - 30 Jun 202028 Jul 20203458%31%11%40%
01 Jul 2019 - 31 Dec 201929 Jan 20204452%36%12%43%
01 Jul 2018 - 31 Dec 201817 Jan 20193941%54%5%57%
01 Jan 2018 - 30 Jun 201831 Jul 20185146%51%3%49%

Payment Time Trends

Payment Distribution Trends

Invoice Payment Practices

This information is as reported by the business, and responses are in their own words.

Payment Terms

Standard payment terms

30 days from the date of the invoice

Were there any changes to the standard payment terms in the reporting period?

No information available

Any other information about payment terms

No additional information

Maximum contractual payment period agreed

60

Dispute Resolution Process

Any disputes would be handled by the finance team addressed to Daniella.toncheva@leadiantbiosciences.com

Other Payment Information

Has this business signed up to a code of conduct or standards on payment practices?

For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.

Does this business offer e-invoicing in relation to qualifying contracts?

This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.

Does this business offer supply chain finance?

This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.

Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?

During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?

No information available

Company Summary

LEADIANT BIOSCIENCES LIMITED is a pharmaceutical company that focuses on developing and providing innovative treatments for rare and ultra-rare diseases. The company is committed to making a positive impact on the lives of patients, while also promoting sustainability in its operations.

The company's sustainability program includes initiatives such as reducing its carbon footprint, promoting responsible waste management, and using sustainable packaging materials. LEADIANT BIOSCIENCES LIMITED also invests in research and development to ensure that its products are safe, effective, and environmentally friendly.

Some of the key products and services offered by LEADIANT BIOSCIENCES LIMITED include treatments for rare diseases such as Duchenne muscular dystrophy and cystinosis. The company also provides support programs for patients and their families, including access to educational resources and financial assistance.

At the helm of LEADIANT BIOSCIENCES LIMITED is CEO Mr. Francesco Maria Picozza, who has over 30 years of experience in the pharmaceutical industry. The company also has a team of dedicated professionals who are committed to making a difference in the lives of patients.

For more information on LEADIANT BIOSCIENCES LIMITED and its products and services, individuals can visit their website at www.leadiant.com. The company's registered office address is located at 70 Chancery Lane, London, WC2A 1AF, United Kingdom.

Financial Metrics

Cash
£1,417,869
Net Worth
£40,221,870
Total Current Assets
£51,089,778
Total Current Liabilities
£10,959,173

Company Location